Elemer Piros
Stock Analyst at Lucid Capital
(0.07)
# 4,721
Out of 5,014 analysts
356
Total ratings
35.1%
Success rate
-7.9%
Average return
Main Sectors:
Stocks Rated by Elemer Piros
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FLNA Filana Therapeutics | Reiterated: Buy | $8 | $0.886 | +802.93% | 6 | Sep 22, 2026 | |
| TVRD Tvardi Therapeutics | Initiated Coverage: Buy | $14 | $1.25 | +1,020.00% | 1 | Sep 8, 2026 | |
| ADIL Adial Pharmaceuticals | Initiated Coverage: Buy | $6 | $4.01 | +49.63% | 1 | Jun 15, 2026 | |
| NRXP NRx Pharmaceuticals | Initiated Coverage: Buy | $49 | $2.92 | +1,578.08% | 1 | May 13, 2026 | |
| PASG Passage Bio | Downgraded: Hold | $68 → $9 | $4.60 | +95.87% | 3 | Apr 20, 2026 | |
| NGEN NervGen Pharma | Initiated Coverage: Buy | $18 | $1.91 | +842.41% | 1 | Apr 15, 2026 | |
| INMB INmune Bio | Upgraded: Buy | $2 → $9 | $1.95 | +361.54% | 4 | Mar 11, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $15 → $22 | $1.03 | +2,035.92% | 2 | Mar 11, 2026 | |
| QNCX Quince Therapeutics | Downgraded: Sell | n/a | $31.12 | - | 3 | Jan 30, 2026 | |
| MNOV MediciNova | Initiated Coverage: Buy | $11 | $1.68 | +556.72% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 → $1 | $0.3078 | +224.89% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.05 | - | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $81 → $2.3 | $3.56 | -35.39% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.03 | n/a | 7 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.5 | $2.49 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $1.29 | n/a | 1 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.11 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $11.00 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $71 | $79.67 | n/a | 7 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 → $120 | $4.70 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.20 | n/a | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $36 | $23.48 | n/a | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $9 | $12.44 | n/a | 12 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $1.30 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $2.38 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $43 → $5.5 | $25.53 | n/a | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.8448 | n/a | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $0.75 | $3.57 | n/a | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $1.27 | n/a | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $0.96 | n/a | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $455 | $4.45 | n/a | 1 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $28 | $38.06 | n/a | 8 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.4963 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.5057 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $0.7142 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 → $13 | $4.08 | n/a | 7 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $24 | $8.27 | n/a | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.22 → $1.79 | $6.82 | n/a | 41 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $77 → $45 | $13.69 | n/a | 5 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8533 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $8 | $0.11353 | n/a | 2 | Dec 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $14.65 | n/a | 16 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $29 → $2 | $5.25 | n/a | 33 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $94 | $24.16 | n/a | 16 | Jul 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 | $65.45 | n/a | 24 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $1.23 | n/a | 17 | Jun 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $67 | $332.56 | n/a | 8 | Jun 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.463 | n/a | 1 | Jun 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $48.15 | n/a | 14 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $24 | $16.20 | n/a | 26 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $7.67 | n/a | 16 | Mar 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $164.19 | n/a | 16 | May 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $19.04 | n/a | 16 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $137.93 | n/a | 3 | Mar 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.88 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.65 | n/a | 1 | Feb 15, 2012 |
Filana Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $8
Current: $0.886
Upside: +802.93%
Tvardi Therapeutics
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $1.25
Upside: +1,020.00%
Adial Pharmaceuticals
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $4.01
Upside: +49.63%
NRx Pharmaceuticals
May 13, 2026
Initiated Coverage: Buy
Price Target: $49
Current: $2.92
Upside: +1,578.08%
Passage Bio
Apr 20, 2026
Downgraded: Hold
Price Target: $68 → $9
Current: $4.60
Upside: +95.87%
NervGen Pharma
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $1.91
Upside: +842.41%
INmune Bio
Mar 11, 2026
Upgraded: Buy
Price Target: $2 → $9
Current: $1.95
Upside: +361.54%
Ocugen
Mar 11, 2026
Reiterated: Buy
Price Target: $15 → $22
Current: $1.03
Upside: +2,035.92%
Quince Therapeutics
Jan 30, 2026
Downgraded: Sell
Price Target: n/a
Current: $31.12
Upside: -
MediciNova
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $1.68
Upside: +556.72%
Dec 17, 2025
Downgraded: Hold
Price Target: $19 → $1
Current: $0.3078
Upside: +224.89%
Dec 11, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $8.05
Upside: -
Oct 21, 2025
Downgraded: Hold
Price Target: $81 → $2.3
Current: $3.56
Upside: -35.39%
Sep 22, 2025
Reiterated: Buy
Price Target: $20
Current: $5.03
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: $5.5
Current: $2.49
Upside: n/a
Jul 31, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $1.29
Upside: n/a
Jul 22, 2025
Initiated Coverage: Buy
Price Target: $8
Current: $1.11
Upside: n/a
Jun 9, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $11.00
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $50 → $71
Current: $79.67
Upside: n/a
Jun 4, 2025
Initiated Coverage: Buy
Price Target: $5 → $120
Current: $4.70
Upside: n/a
Feb 20, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $1.20
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $42 → $36
Current: $23.48
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $30 → $9
Current: $12.44
Upside: n/a
Dec 11, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $1.30
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $17
Current: $2.38
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: $43 → $5.5
Current: $25.53
Upside: n/a
Sep 30, 2024
Initiated Coverage: Buy
Price Target: $17
Current: $0.8448
Upside: n/a
Sep 4, 2024
Downgraded: Hold
Price Target: $22 → $0.75
Current: $3.57
Upside: n/a
Jul 2, 2024
Reiterated: Buy
Price Target: $67
Current: $1.27
Upside: n/a
Jun 13, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $0.96
Upside: n/a
Jun 12, 2024
Initiated Coverage: Buy
Price Target: $455
Current: $4.45
Upside: n/a
Apr 4, 2024
Reiterated: Buy
Price Target: $21 → $28
Current: $38.06
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $68
Current: $0.4963
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $40
Current: $0.5057
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $14
Current: $0.7142
Upside: n/a
Mar 8, 2023
Initiated Coverage: Buy
Price Target: $11 → $13
Current: $4.08
Upside: n/a
Oct 27, 2021
Reiterated: Buy
Price Target: $32 → $24
Current: $8.27
Upside: n/a
Mar 15, 2021
Reiterated: Hold
Price Target: $1.22 → $1.79
Current: $6.82
Upside: n/a
Mar 2, 2021
Reiterated: Sell
Price Target: $77 → $45
Current: $13.69
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $9
Current: $0.8533
Upside: n/a
Dec 1, 2020
Reiterated: Buy
Price Target: $14 → $8
Current: $0.11353
Upside: n/a
Sep 10, 2019
Reiterated: Buy
Price Target: $23
Current: $14.65
Upside: n/a
Aug 12, 2019
Downgraded: Hold
Price Target: $29 → $2
Current: $5.25
Upside: n/a
Jul 8, 2019
Reiterated: Buy
Price Target: $81 → $94
Current: $24.16
Upside: n/a
Jun 27, 2019
Downgraded: Hold
Price Target: $24
Current: $65.45
Upside: n/a
Jun 25, 2019
Reiterated: Buy
Price Target: $35 → $33
Current: $1.23
Upside: n/a
Jun 24, 2019
Reiterated: Buy
Price Target: $34 → $67
Current: $332.56
Upside: n/a
Jun 20, 2019
Initiated Coverage: Buy
Price Target: $7
Current: $0.463
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $7
Current: $48.15
Upside: n/a
Mar 19, 2019
Reiterated: Buy
Price Target: $18 → $24
Current: $16.20
Upside: n/a
Mar 7, 2019
Reiterated: Buy
Price Target: $24
Current: $7.67
Upside: n/a
May 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $164.19
Upside: n/a
Mar 1, 2018
Reiterated: Hold
Price Target: $19
Current: $19.04
Upside: n/a
Mar 23, 2016
Reiterated: Buy
Price Target: $7
Current: $137.93
Upside: n/a
Mar 9, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $3.88
Upside: n/a
Feb 15, 2012
Reiterated: Hold
Price Target: n/a
Current: $72.65
Upside: n/a